PubMed:12618764 / 0-127 JSONTXT

Annnotations TAB JSON ListView MergeView

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":127},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":127},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion."}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"12618764-0#0#4#gene5607","span":{"begin":0,"end":4},"obj":"gene5607"},{"id":"12618764-0#39#65#diseaseC0936223","span":{"begin":39,"end":65},"obj":"diseaseC0936223"},{"id":"12618764-0#39#65#diseaseC1282496","span":{"begin":39,"end":65},"obj":"diseaseC1282496"}],"relations":[{"id":"0#4#gene560739#65#diseaseC0936223","pred":"associated_with","subj":"12618764-0#0#4#gene5607","obj":"12618764-0#39#65#diseaseC0936223"},{"id":"0#4#gene560739#65#diseaseC1282496","pred":"associated_with","subj":"12618764-0#0#4#gene5607","obj":"12618764-0#39#65#diseaseC1282496"}],"text":"MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion."}

    DisGeNet-2017-sample

    {"project":"DisGeNet-2017-sample","denotations":[{"id":"T69","span":{"begin":0,"end":4},"obj":"gene:5607"},{"id":"T70","span":{"begin":39,"end":65},"obj":"disease:C0936223"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T69","obj":"T70"},{"id":"R2","pred":"associated_with","subj":"T69","obj":"T70"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion."}

    CoMAGC

    {"project":"CoMAGC","denotations":[{"id":"T1","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"E1","span":{"begin":5,"end":19},"obj":"Gene_expression"},{"id":"E2","span":{"begin":5,"end":19},"obj":"Positive_regulation"},{"id":"T2","span":{"begin":50,"end":65},"obj":"prostate cancer"}],"relations":[{"id":"R1","pred":"themeOf","subj":"T1","obj":"E1"},{"id":"R2","pred":"themeOf","subj":"E1","obj":"E2"},{"id":"R3","pred":"CGE-increased","subj":"T1","obj":"T2"},{"id":"R4","pred":"CCS-normalTOcancer","subj":"T1","obj":"T2"},{"id":"R5","pred":"PT-causality","subj":"T1","obj":"T2"},{"id":"R3","pred":"IGE-unchanged","subj":"T1","obj":"T2"}],"text":"MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion."}